Tasuku Honjo Publications of Tasuku Honjo, 2018 Nobel Laureate in Physiology or Medicine, in The Journal of Immunology:

 

Pillars Article: Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme. Cell. 2000. 102: 553–563
Masamichi Muramatsu, Kazuo Kinoshita, Sidonia Fagarasan, Shuichi Yamada, Yoichi Shinkai and Tasuku Honjo
J Immunol November 2018, 201:2530-2540

An Evolutionary View of the Mechanism for Immune and Genome Diversity
Lucia Kato, Andre Stanlie, Nasim A. Begum, Maki Kobayashi, Masatoshi Aida and Tasuku Honjo
J Immunol April 2012, 188:3559-3566; doi:10.4049/jimmunol.1102397

IFN-α Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity
Seigo Terawaki, Shunsuke Chikuma, Shiro Shibayama, Tamon Hayashi, Takao Yoshida, Taku Okazaki and Tasuku Honjo
J Immunol March 2011, 186:2772-2779; doi:10.4049/jimmunol.1003208

Anti-Programmed Cell Death 1 Antibody Reduces CD4+PD-1+ T Cells and Relieves the Lupus-Like Nephritis of NZB/W F1 Mice
Shimpei Kasagi, Seiji Kawano, Taku Okazaki, Tasuku Honjo, Akio Morinobu, Saori Hatachi, Kenichiro Shimatani, Yoshimasa Tanaka, Nagahiro Minato and Shunichi Kumagai
J Immunol March 2010, 184:2337-2347; doi:10.4049/jimmunol.0901652

PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo
Shunsuke Chikuma, Seigo Terawaki, Tamon Hayashi, Ryusuke Nabeshima, Takao Yoshida, Shiro Shibayama, Taku Okazaki and Tasuku Honjo
J Immunol June 2009, 182:6682-6689; doi:10.4049/jimmunol.0900080

AID−/−μs−/− Mice Are Agammaglobulinemic and Fail to Maintain B220−CD138+ Plasma Cells
Kaori Kumazaki, Boaz Tirosh, René Maehr, Marianne Boes, Tasuku Honjo and Hidde L. Ploegh
J Immunol February 2007, 178:2192-2203; doi:10.4049/jimmunol.178.4.2192

Differential Effects of B and T Lymphocyte Attenuator and Programmed Death-1 on Acceptance of Partially versus Fully MHC-Mismatched Cardiac Allografts
Ran Tao, Liqing Wang, Rongxiang Han, Tao Wang, Qunrui Ye, Takasu Honjo, Theresa L. Murphy, Kenneth M. Murphy and Wayne W. Hancock
J Immunol November 2005, 175:5774-5782; doi:10.4049/jimmunol.175.9.5774

Absence of Programmed Death Receptor 1 Alters Thymic Development and Enhances Generation of CD4/CD8 Double-Negative TCR-Transgenic T Cells
Christian Blank, Ian Brown, Reinhard Marks, Hiroyuki Nishimura, Tasuku Honjo and Thomas F. Gajewski
J Immunol November 2003, 171:4574-4581; doi:10.4049/jimmunol.171.9.4574

Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Autoimmune Disease
Tetsuya Higuchi, Yuichi Aiba, Takashi Nomura, Junichiro Matsuda, Keiji Mochida, Misao Suzuki, Hitoshi Kikutani, Tasuku Honjo, Kiyoshi Nishioka and Takeshi Tsubata
J Immunol January 2002, 168:9-12; doi:10.4049/jimmunol.168.1.9

Differential Roles of Cytokine Receptors in the Development of Epidermal γδ T Cells
Sang-Kyu Ye, Kazushige Maki, Hai-Chon Lee, Akiko Ito, Kazuhiro Kawai, Haruhiko Suzuki, Tak W. Mak, Yueh-hsiu Chien, Tasuku Honjo and Koichi Ikuta
J Immunol August 2001, 167:1929-1934; doi:10.4049/jimmunol.167.4.1929

Induction of Germline Transcription in the Human TCRγ Locus by STAT5
Hai-Chon Lee, Sang-Kyu Ye, Tasuku Honjo and Koichi Ikuta
J Immunol July 2001, 167:320-326; doi:10.4049/jimmunol.167.1.320

Increased Frequency of Surface IgA-Positive Plasma Cells in the Intestinal Lamina Propria and Decreased IgA Excretion in Hyper IgA (HIGA) Mice, a Murine Model of IgA Nephropathy with Hyperserum IgA
Tadashi Kamata, Fumiaki Nogaki, Sidonia Fagarasan, Toshio Sakiyama, Ikei Kobayashi, Shigeki Miyawaki, Koichi Ikuta, Eri Muso, Haruyoshi Yoshida, Shigetake Sasayama and Tasuku Honjo
J Immunol August 2000, 165:1387-1394; doi:10.4049/jimmunol.165.3.1387

Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs
T Akamizu, F Matsuda, J Okuda, H Li, H Kanda, T Watanabe, T Honjo and T Mori
J Immunol October 1996, 157:3148-3152

IL-2 can support growth of CD8+ T cells but not CD4+ T cells of human IL-2 receptor beta-chain transgenic mice
M Asano, Y Ishida, H Sabe, M Kondo, K Sugamura and T Honjo
J Immunol December 1994, 153:5373-5381

Variable regions of Ig heavy chain genes encoding antithyrotropin receptor antibodies of patients with Graves' disease
E K Shin, T Akamizu, F Matsuda, H Sugawa, J Fujikura, T Mori and T Honjo
J Immunol February 1994, 152:1485-1492

Structural analysis of the human VH locus using nonrepetitive intergenic probes and repetitive sequence probes. Evidence for recent reshuffling
R Matsumura, F Matsuda, H Nagaoka, J Fujikura, E K Shin, Y Fukita, M Haino and T Honjo
J Immunol January 1994, 152:660-666

Control of IL-2 receptor-alpha expression by IL-1, tumor necrosis factor, and IL-2. Complex regulation via elements in the 5' flanking region
G Plaetinck, M C Combe, P Corthésy, P Sperisen, H Kanamori, T Honjo and M Nabholz
J Immunol November 1990, 145:3340-3347

Expression of murine IL-2 receptor beta-chain on thymic and splenic lymphocyte subpopulations as revealed by the IL-2-induced proliferative response in human IL-2 receptor alpha-chain transgenic mice
M Hattori, H Okazaki, Y Ishida, M Onuma, S Kano, T Honjo and N Minato
J Immunol May 1990, 144:3809-3815

Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells
K W Beagley, J H Eldridge, H Kiyono, M P Everson, W J Koopman, T Honjo and J R McGhee
J Immunol September 1988, 141:2035-2042

Both B151-T cell replacing factor 1 and IL-5 regulate Ig secretion and IL-2 receptor expression on a cloned B lymphoma line
K Nakanishi, T Yoshimoto, Y Katoh, S Ono, K Matsui, K Hiroishi, T Noma, T Honjo, K Takatsu and K Higashino
J Immunol February 1988, 140:1168-1174

Regulation of murine IgE production in SJA/9 and nude mice. Potentiation of IgE production by recombinant interleukin 4
M Azuma, T Hirano, H Miyajima, N Watanabe, H Yagita, S Enomoto, S Furusawa, Z Ovary, T Kinashi and T Honjo
J Immunol October 1987, 139:2538-2544

Expression of interleukin 2 receptors on interleukin 3-dependent cell lines
S Koyasu, J Yodoi, T Nikaido, Y Tagaya, Y Taniguchi, T Honjo and I Yahara
J Immunol February 1986, 136:984-987

TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines
M Okada, M Maeda, Y Tagaya, Y Taniguchi, K Teshigawara, T Yoshiki, T Diamantstein, K A Smith, T Uchiyama and T Honjo
J Immunol December 1985, 135:3995-4003

TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells)
J Yodoi, K Teshigawara, T Nikaido, K Fukui, T Noma, T Honjo, M Takigawa, M Sasaki, N Minato and M Tsudo
J Immunol March 1985, 134:1623-1630

Relationship between the rearrangement of immunoglobulin genes, the appearance of a B lymphocyte antigen, and immunoglobulin synthesis in murine pre-B cell lines
H Sugiyama, S Akira, N Yoshida, S Kishimoto, Y Yamamura, P Kincade, T Honjo and T Kishimoto
J Immunol June 1982, 128:2793-2797

Induction and regulation of immunoglobulin expression in a murine pre-B cell line, 70Z/3. I. Cell cycle-associated induction of sIgM expression and kappa-chain synthesis in 70Z/3 cells by LPS stimulation
N Sakaguchi, T Kishimoto, H Kikutani, T Watanabe, N Yoshida, A Shimizu, Y Yamawaki-Kataoka, T Honjo and Y Yamamura
J Immunol December 1980, 125:2654-2659

© The American Association of Immunologists, Inc.
1451 Rockville Pike, Suite 650, Rockville, Maryland 20852
Phone: (301) 634-7178 | Fax: (301) 634-7887